SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-001226
Filing Date
2023-02-14
Accepted
2023-02-14 07:46:13
Documents
17
Period of Report
2023-02-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230214x8k.htm   iXBRL 8-K 38022
2 EX-99.1 tmb-20230214xex99d1.htm EX-99.1 27401
3 GRAPHIC tmb-20230214xex99d1001.jpg GRAPHIC 14345
4 GRAPHIC tmb-20230214xex99d1002.jpg GRAPHIC 9237
  Complete submission text file 0001558370-23-001226.txt   323802

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20230214.xsd EX-101.SCH 4049
6 EX-101.DEF tmb-20230214_def.xml EX-101.DEF 3491
7 EX-101.LAB tmb-20230214_lab.xml EX-101.LAB 632
8 EX-101.PRE tmb-20230214_pre.xml EX-101.PRE 10407
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230214x8k_htm.xml XML 4841
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 23622555
SIC: 2834 Pharmaceutical Preparations